Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis

Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular metabolism (Germany) 2019-01, Vol.19, p.97-106
Hauptverfasser: Wolff, G., Taranko, A.E., Meln, I., Weinmann, J., Sijmonsma, T., Lerch, S., Heide, D., Billeter, A.T., Tews, D., Krunic, D., Fischer-Posovszky, P., Müller-Stich, B.P., Herzig, S., Grimm, D., Heikenwälder, M., Kao, W.W., Vegiopoulos, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue
container_start_page 97
container_title Molecular metabolism (Germany)
container_volume 19
creator Wolff, G.
Taranko, A.E.
Meln, I.
Weinmann, J.
Sijmonsma, T.
Lerch, S.
Heide, D.
Billeter, A.T.
Tews, D.
Krunic, D.
Fischer-Posovszky, P.
Müller-Stich, B.P.
Herzig, S.
Grimm, D.
Heikenwälder, M.
Kao, W.W.
Vegiopoulos, A.
description Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications. Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling. Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance. These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome. •The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.
doi_str_mv 10.1016/j.molmet.2018.10.007
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6323191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2212877818308378</els_id><sourcerecordid>2132276802</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</originalsourceid><addsrcrecordid>eNp9UUtvEzEQtlARrUr_AUI-ctnUj429viChFmilSFzgbDn2OHHYtYPtrZp_zy4pfVw6lxnN4_tm5kPoAyULSqi43C2G1A9QF4zQbkotCJFv0BljlDWdlN3Js_gUXZSyI5N1QoglfYdOOWmJkoSfod_XAWrjYA_RQazYj9HWkCJOHtctYLiv2Vjo-7E3GQ-m5nCP9zlVSJv-YE3Eq3EIsw_TzBpKqAdsosObfrSpAN6mAVKppoTyHr31pi9w8eDP0a9vX39e3TSrH99vr76sGtsKXhtOl9K21Bnp7ZJ1nEtCWr-20oGwUlDHu0450lrpnfKSW2UVCKXkWilPieTn6PMRdz-uB3B2uiubXu9zGEw-6GSCflmJYas36U4LzjhVdAL49ACQ058RStVDKPMTTIQ0Fs0oZ0yKjrCptT222pxKyeAfaSjRs1R6p49S6VmqOUv-rfjx-YqPQ_-FeboBpkfdBci62ADRggsZbNUuhdcZ_gJJkKom</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2132276802</pqid></control><display><type>article</type><title>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wolff, G. ; Taranko, A.E. ; Meln, I. ; Weinmann, J. ; Sijmonsma, T. ; Lerch, S. ; Heide, D. ; Billeter, A.T. ; Tews, D. ; Krunic, D. ; Fischer-Posovszky, P. ; Müller-Stich, B.P. ; Herzig, S. ; Grimm, D. ; Heikenwälder, M. ; Kao, W.W. ; Vegiopoulos, A.</creator><creatorcontrib>Wolff, G. ; Taranko, A.E. ; Meln, I. ; Weinmann, J. ; Sijmonsma, T. ; Lerch, S. ; Heide, D. ; Billeter, A.T. ; Tews, D. ; Krunic, D. ; Fischer-Posovszky, P. ; Müller-Stich, B.P. ; Herzig, S. ; Grimm, D. ; Heikenwälder, M. ; Kao, W.W. ; Vegiopoulos, A.</creatorcontrib><description>Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications. Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling. Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance. These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome. •The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.</description><identifier>ISSN: 2212-8778</identifier><identifier>EISSN: 2212-8778</identifier><identifier>DOI: 10.1016/j.molmet.2018.10.007</identifier><identifier>PMID: 30409703</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Adipocytes - metabolism ; Adipose ; Adipose Tissue - metabolism ; Adipose Tissue, White - metabolism ; Adiposity - drug effects ; Adult ; Animals ; Brief Communication ; Diet, High-Fat ; ECM ; Extracellular Matrix - metabolism ; Female ; Glucose - metabolism ; Homeostasis ; Humans ; Inflammation ; Insulin ; Insulin Resistance ; Intra-Abdominal Fat - metabolism ; Liver - metabolism ; Lumican ; Lumican - genetics ; Lumican - metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Middle Aged ; Non-alcoholic Fatty Liver Disease - metabolism ; Obesity ; Obesity - metabolism ; Proteoglycans - metabolism</subject><ispartof>Molecular metabolism (Germany), 2019-01, Vol.19, p.97-106</ispartof><rights>2018 The Authors</rights><rights>Copyright © 2018 The Authors. Published by Elsevier GmbH.. All rights reserved.</rights><rights>2018 The Authors 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</citedby><cites>FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323191/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323191/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30409703$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolff, G.</creatorcontrib><creatorcontrib>Taranko, A.E.</creatorcontrib><creatorcontrib>Meln, I.</creatorcontrib><creatorcontrib>Weinmann, J.</creatorcontrib><creatorcontrib>Sijmonsma, T.</creatorcontrib><creatorcontrib>Lerch, S.</creatorcontrib><creatorcontrib>Heide, D.</creatorcontrib><creatorcontrib>Billeter, A.T.</creatorcontrib><creatorcontrib>Tews, D.</creatorcontrib><creatorcontrib>Krunic, D.</creatorcontrib><creatorcontrib>Fischer-Posovszky, P.</creatorcontrib><creatorcontrib>Müller-Stich, B.P.</creatorcontrib><creatorcontrib>Herzig, S.</creatorcontrib><creatorcontrib>Grimm, D.</creatorcontrib><creatorcontrib>Heikenwälder, M.</creatorcontrib><creatorcontrib>Kao, W.W.</creatorcontrib><creatorcontrib>Vegiopoulos, A.</creatorcontrib><title>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</title><title>Molecular metabolism (Germany)</title><addtitle>Mol Metab</addtitle><description>Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications. Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling. Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance. These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome. •The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.</description><subject>Adipocytes - metabolism</subject><subject>Adipose</subject><subject>Adipose Tissue - metabolism</subject><subject>Adipose Tissue, White - metabolism</subject><subject>Adiposity - drug effects</subject><subject>Adult</subject><subject>Animals</subject><subject>Brief Communication</subject><subject>Diet, High-Fat</subject><subject>ECM</subject><subject>Extracellular Matrix - metabolism</subject><subject>Female</subject><subject>Glucose - metabolism</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Intra-Abdominal Fat - metabolism</subject><subject>Liver - metabolism</subject><subject>Lumican</subject><subject>Lumican - genetics</subject><subject>Lumican - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Middle Aged</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>Proteoglycans - metabolism</subject><issn>2212-8778</issn><issn>2212-8778</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UUtvEzEQtlARrUr_AUI-ctnUj429viChFmilSFzgbDn2OHHYtYPtrZp_zy4pfVw6lxnN4_tm5kPoAyULSqi43C2G1A9QF4zQbkotCJFv0BljlDWdlN3Js_gUXZSyI5N1QoglfYdOOWmJkoSfod_XAWrjYA_RQazYj9HWkCJOHtctYLiv2Vjo-7E3GQ-m5nCP9zlVSJv-YE3Eq3EIsw_TzBpKqAdsosObfrSpAN6mAVKppoTyHr31pi9w8eDP0a9vX39e3TSrH99vr76sGtsKXhtOl9K21Bnp7ZJ1nEtCWr-20oGwUlDHu0450lrpnfKSW2UVCKXkWilPieTn6PMRdz-uB3B2uiubXu9zGEw-6GSCflmJYas36U4LzjhVdAL49ACQ058RStVDKPMTTIQ0Fs0oZ0yKjrCptT222pxKyeAfaSjRs1R6p49S6VmqOUv-rfjx-YqPQ_-FeboBpkfdBci62ADRggsZbNUuhdcZ_gJJkKom</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Wolff, G.</creator><creator>Taranko, A.E.</creator><creator>Meln, I.</creator><creator>Weinmann, J.</creator><creator>Sijmonsma, T.</creator><creator>Lerch, S.</creator><creator>Heide, D.</creator><creator>Billeter, A.T.</creator><creator>Tews, D.</creator><creator>Krunic, D.</creator><creator>Fischer-Posovszky, P.</creator><creator>Müller-Stich, B.P.</creator><creator>Herzig, S.</creator><creator>Grimm, D.</creator><creator>Heikenwälder, M.</creator><creator>Kao, W.W.</creator><creator>Vegiopoulos, A.</creator><general>Elsevier GmbH</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</title><author>Wolff, G. ; Taranko, A.E. ; Meln, I. ; Weinmann, J. ; Sijmonsma, T. ; Lerch, S. ; Heide, D. ; Billeter, A.T. ; Tews, D. ; Krunic, D. ; Fischer-Posovszky, P. ; Müller-Stich, B.P. ; Herzig, S. ; Grimm, D. ; Heikenwälder, M. ; Kao, W.W. ; Vegiopoulos, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-3157c41da7fc528337004fbc7de6c761d3889d04c7fd9f73c9c9e6997b99f1073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adipocytes - metabolism</topic><topic>Adipose</topic><topic>Adipose Tissue - metabolism</topic><topic>Adipose Tissue, White - metabolism</topic><topic>Adiposity - drug effects</topic><topic>Adult</topic><topic>Animals</topic><topic>Brief Communication</topic><topic>Diet, High-Fat</topic><topic>ECM</topic><topic>Extracellular Matrix - metabolism</topic><topic>Female</topic><topic>Glucose - metabolism</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Intra-Abdominal Fat - metabolism</topic><topic>Liver - metabolism</topic><topic>Lumican</topic><topic>Lumican - genetics</topic><topic>Lumican - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Middle Aged</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>Proteoglycans - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolff, G.</creatorcontrib><creatorcontrib>Taranko, A.E.</creatorcontrib><creatorcontrib>Meln, I.</creatorcontrib><creatorcontrib>Weinmann, J.</creatorcontrib><creatorcontrib>Sijmonsma, T.</creatorcontrib><creatorcontrib>Lerch, S.</creatorcontrib><creatorcontrib>Heide, D.</creatorcontrib><creatorcontrib>Billeter, A.T.</creatorcontrib><creatorcontrib>Tews, D.</creatorcontrib><creatorcontrib>Krunic, D.</creatorcontrib><creatorcontrib>Fischer-Posovszky, P.</creatorcontrib><creatorcontrib>Müller-Stich, B.P.</creatorcontrib><creatorcontrib>Herzig, S.</creatorcontrib><creatorcontrib>Grimm, D.</creatorcontrib><creatorcontrib>Heikenwälder, M.</creatorcontrib><creatorcontrib>Kao, W.W.</creatorcontrib><creatorcontrib>Vegiopoulos, A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular metabolism (Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolff, G.</au><au>Taranko, A.E.</au><au>Meln, I.</au><au>Weinmann, J.</au><au>Sijmonsma, T.</au><au>Lerch, S.</au><au>Heide, D.</au><au>Billeter, A.T.</au><au>Tews, D.</au><au>Krunic, D.</au><au>Fischer-Posovszky, P.</au><au>Müller-Stich, B.P.</au><au>Herzig, S.</au><au>Grimm, D.</au><au>Heikenwälder, M.</au><au>Kao, W.W.</au><au>Vegiopoulos, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis</atitle><jtitle>Molecular metabolism (Germany)</jtitle><addtitle>Mol Metab</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>19</volume><spage>97</spage><epage>106</epage><pages>97-106</pages><issn>2212-8778</issn><eissn>2212-8778</eissn><abstract>Extracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications. Whole body ablation of Lumican (Lum−/−) gene and adeno-associated virus-mediated over-expression were used in combination with control or high fat diet to assess energy balance, glucose homeostasis as well as adipose tissue health and remodeling. Lumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance. These data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome. •The extracellular matrix proteoglycan Lumican (Lum) is particularly enriched in stromal cells within white adipose tissue.•Visceral fat from obese patients displays increased levels of Lum compared to subcutaneous fat.•Lum-Ko female mice exhibit decreased insulin sensitivity and increased triglycerides upon high-fat diet (HFD) feeding.•Lum-Ko female mice on HFD have increased inflammation in white fat in the absence of overt effects on adipocyte formation.•· Lum over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>30409703</pmid><doi>10.1016/j.molmet.2018.10.007</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2212-8778
ispartof Molecular metabolism (Germany), 2019-01, Vol.19, p.97-106
issn 2212-8778
2212-8778
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6323191
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adipocytes - metabolism
Adipose
Adipose Tissue - metabolism
Adipose Tissue, White - metabolism
Adiposity - drug effects
Adult
Animals
Brief Communication
Diet, High-Fat
ECM
Extracellular Matrix - metabolism
Female
Glucose - metabolism
Homeostasis
Humans
Inflammation
Insulin
Insulin Resistance
Intra-Abdominal Fat - metabolism
Liver - metabolism
Lumican
Lumican - genetics
Lumican - metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Middle Aged
Non-alcoholic Fatty Liver Disease - metabolism
Obesity
Obesity - metabolism
Proteoglycans - metabolism
title Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A13%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diet-dependent%20function%20of%20the%20extracellular%20matrix%20proteoglycan%20Lumican%20in%20obesity%20and%20glucose%20homeostasis&rft.jtitle=Molecular%20metabolism%20(Germany)&rft.au=Wolff,%20G.&rft.date=2019-01-01&rft.volume=19&rft.spage=97&rft.epage=106&rft.pages=97-106&rft.issn=2212-8778&rft.eissn=2212-8778&rft_id=info:doi/10.1016/j.molmet.2018.10.007&rft_dat=%3Cproquest_pubme%3E2132276802%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2132276802&rft_id=info:pmid/30409703&rft_els_id=S2212877818308378&rfr_iscdi=true